NDC 42291-301-30 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-301
- Requested NDC
- 42291-301-30
- Package NDCs from labels
- 42291-301-50, 42291-301-30
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-301-10 | EA - Each | 42291-301 | 2148c67a-da4a-4fc6-9965-d2dc7283324f | 1 | 2013-02-13 |
| 42291-301-18 | EA - Each | 42291-301 | a94c3a5a-b7d2-4162-bcc7-69c42cf25512 | 1 | 2013-02-13 |
| 42291-301-27 | EA - Each | 42291-301 | a3157c8a-e4c6-4912-b9da-4665436ad940 | 1 | 2013-02-13 |
| 42291-301-30 | EA - Each | 42291-301 | 4b3388ae-99e2-4ac5-a747-7f90798c60a8 | 1 | 2013-02-13 |
| 42291-301-50 | EA - Each | 42291-301 | 5f4b3f45-a21d-4e20-a2e3-3296ff0a4325 | 1 | 2018-10-11 |
| 42291-301-90 | EA - Each | 42291-301 | 7169cf0d-6ae5-416d-81f2-8160bb398680 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 0e1d17d5-d39c-4144-aac0-7c0d3bc9ec0d | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 2343e3a1-82d0-4c70-a086-a01a0ce81ef3 | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 67330eef-c976-4862-b1ae-20f30f43df76 | 2026-02-09 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 2e331641-ec26-4d76-b16b-a9863c767afe | 2026-02-06 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | cc1998a7-7004-4688-8b5b-525041851d1d | 2026-02-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 4aa69d04-6b32-4764-a48b-ef5313dd95d3 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 60b46f6d-efbc-487a-b672-b20df8b44cc4 | 2026-01-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 43a3ec78-8235-4d46-a343-2f9226745a39 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 685553b0-384e-400b-a8ae-612ceece8261 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 7ea0b220-edbb-45eb-aeb3-65283f8489a1 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | bff3beea-1f05-4e84-bcd2-d05782acddae | 2026-01-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | DIRECT RX | 29a70e2d-d3fd-4e32-95dd-7ee721d87388 | 2026-01-08 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| gabapentin | GABAPENTIN | Coupler LLC | 47cd25f6-e123-9aaf-e063-6394a90aeedd | 2026-01-07 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABARONE | GABAPENTIN | INA Pharmaceutics Inc. | 0f350a4b-f294-4b98-b69f-3cc789e930ba | 2026-01-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ajenat Pharmaceuticals LLC | 02304deb-7b4a-452f-9b1a-64ca0aedbcc2 | 2025-12-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Northwind Health Company, LLC | 471b2d32-0cbd-aade-e063-6394a90a1696 | 2025-12-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | ST. MARY'S MEDICAL PARK PHARMACY | 3aaf3d6e-c6d5-89f5-e063-6394a90a9b77 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Northwind Health Company, LLC | 47214c7c-ba1b-9107-e063-6294a90a5431 | 2025-12-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | BioComp Pharma, Inc. | 0b3a4009-42f3-c84f-e063-6294a90a8068 | 2025-12-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | b86c81d9-9a4a-4847-be18-520e5cc5dc4b | 2025-12-12 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.